alexa Acute lymphocytic leukemia | United States| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

Acute Lymphocytic Leukemia

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Acute lymphocytic leukemia

     Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia (ALL), is an acute form ofleukemia, or cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblastsALL, lymphoblasts are overproduced in the bone marrow and continuously multiply, causing damage and death by inhibiting the production of normal cells (such as red and white blood cells and platelets) in the bone marrow and by spreading (infiltrating) to other organs. ALL is most common in childhood, with a peak incidence at 2–5 years of age and another peak in old age.

    Typical symptoms

    • Generalized weakness and fatigue, Anemia, Dizziness, Weight loss and/or loss of appetite, Excessive and unexplained bruising, Bone pain, joint pain (caused by the spread of "blast" cells to the surface of the bone or into the joint from the marrow cavity), Enlarged lymph nodes, liver and/or spleen, Petechiae, which are tiny red spots or lines in the skin due to low platelet levels.


  • Acute lymphocytic leukemia

     Treatment and Medication

    Chemotherapy, Remission induction, Consolidation, Maintenance therapy, Immunotherapy, Biological therapy, Radiation therapy.

  • Acute lymphocytic leukemia


    In the United States, the annual incidence of ALL is roughly 6,000 in ratio 3,000-3,500, or approximately 1 in 50,000. ALL is slightly more common in males than females. In the United States in 2010, incidence from birth to age 19 was 38.4 per 1,000,000 per year in boys and 30.2 per 1,000,000 per year in girls. Prevalence was 30,171, and observed survival was 90% (based on data from 2003-2009). ALL has a bimodal age distribution, having a high incidence in ages 2–5 and another peak in incidence above 50 years old.

Expert PPTs

Speaker PPTs


High Impact List of Articles

Conference Proceedings